Mometasone/formoterol

Mometasone/formoterol is a medication that combines mometasone furoate, a corticosteroid, and formoterol, a long-acting beta2-adrenergic agonist (LABA). It is used in the management of asthma and chronic obstructive pulmonary disease (COPD).

Mometasone furoate and formoterol

Medical uses

Mometasone/formoterol is used for the long-term treatment of asthma in people aged 12 years and older. It is also used to prevent bronchospasm in people with COPD, including chronic bronchitis and emphysema.

Contraindications

Mometasone/formoterol is contraindicated in patients with a known hypersensitivity to mometasone, formoterol, or any of the ingredients in the medication. It is also contraindicated in patients with status asthmaticus or acute episodes of asthma or COPD requiring intensive measures.

Side effects

Common side effects of mometasone/formoterol include headache, throat irritation, and upper respiratory tract infection. Serious side effects may include worsening of asthma or COPD, cardiovascular effects, and paradoxical bronchospasm.

Pharmacology

Mometasone furoate is a corticosteroid that reduces inflammation, while formoterol is a LABA that relaxes the muscles in the airways to improve breathing.

History

Mometasone/formoterol was approved for medical use in the United States in 2010.

See also

• List of corticosteroids
• List of beta2-adrenergic agonists